Reduction in clot strength.kaolin induced 30M after maximum clot amplitude after addition of heparinase:LenFr:Pt:Bld:Qn:Thromboelastography

Preferred Label : Reduction in clot strength.kaolin induced 30M after maximum clot amplitude after addition of heparinase:LenFr:Pt:Bld:Qn:Thromboelastography;

LOINC status : ACTIVE;

LOINC display name : Reduction in kaolin induced clot strength [Length fraction] in Blood by Thromboelastography 30 min p max clot amplitude heparinase;

LOINC long common name : Reduction in kaolin induced clot strength [Length fraction] in Blood by Thromboelastography 30 min p max clot amplitude heparinase;

LOINC short name : Rd.clot.kaolin.ind 30M p MA hep LenFr B;

Détails

Origin ID

102003-1;

UMLS CUI

C5831266;

Has challenge
- 30 min p max clot amplitude + heparinase [LOINC Challenge]
- addition of heparinase [LOINC Challenge]
- after addition of heparinase [LOINC Challenge]
- after maximum clot amplitude [LOINC Challenge]
- heparinase [LOINC Challenge]
Has component
- Clot [LOINC component]
- Clot strength [LOINC component]
- Reduction in clot strength.kaolin induced^30M after maximum clot amplitude after addition of heparinase [LOINC component]
- Reduction in clot strength.kaolin-induced^30M after maximum clot amplitude after addition of heparinase [LOINC component]
- Reduction in kaolin induced clot strength [LOINC component]
- Strength [LOINC component]
Has method
- Thromboelastography [LOINC method]
Has property
- Length fraction [LOINC Property]
Has system
- Blood [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients